Skip to main content
Equibles

LOOMIS SAYLES & CO L P

Position in FTRE — Fortrea Holdings Inc.

CIK 312348 BOSTON, MA
Back to FTRE Full portfolio

Position in FTRE

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$42,466,144
+$25,295,661 QoQ
Shares Held
2,440,583
+33.9% QoQ
Ownership
2.57%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#12
of 334 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 98% Shared 0% None 2%

Common Shares in FTRE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

LOOMIS SAYLES & CO L P holds $4,120,076,195 across 24 Biotechnology names. FTRE ranks #13 (1.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,920,953 $1,947,654,982
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,859,172 $1,159,268,108
3 ALNY
Alnylam Pharmaceuticals, Inc.
 580,187 $174,653,692
4 LGND
Ligand Pharmaceuticals Inc
 291,805 $92,236,641
5 TWST
Twist Bioscience Corp
 861,309 $88,611,468
6 AXSM
Axsome Therapeutics, Inc.
 239,490 $58,619,966
7 VCEL
Vericel Corp
 1,200,239 $53,398,633
8 MIRM
Mirum Pharmaceuticals, Inc.
 443,636 $51,936,466

All Filings in FTRE

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $42,466,144 2,440,583
2026-03-31 $17,170,483 1,822,769